Gregory J. Bullington
Co-Founder & CEO

Greg has lead all aspects of company development for Magnolia Medical Technologies over the past 5 years including independent clinical trials, intellectual property strategy, peer-reviewed journal publication and overall commercialization efforts.

Greg has extensive experience in the healthcare space having lead product commercialization and strategy engagements for large-scale biotech, healthcare insurance and medical technology platform providers.

Greg began his career in professional services with the Audit & Assurance practice of Deloitte & Touche LLP. He continued his professional development as a management consultant, working for Lake Partners, a Seattle-based strategy firm. In 2006, Greg founded Forum Ventures, a technology commercialization consultancy focused on accelerating the growth of early and mid-stage technology companies. 

Over the past decade, Greg has lead engagements and worked with senior executive teams at over 50 companies ranging from Fortune 100 corporations to venture-backed and early stage startups as a consultant, advisor and investor.

Richard G. Patton, M.D.
Co-Founder & Medical Director

Dr. Patton is a board-certified pathologist with more than 35 years of active practice experience. Recognizing the patient safety and financial implications of false positive blood cultures, he has long been interested in exploring opportunities to reduce contamination rates.

In 2006, Dr. Patton designed a clinical trial to test the effectiveness of Initial Specimen Diversion Technique (ISDT), an innovation that he conceived earlier in his career. The results of the trial were significantly positive and recently published in the peer-reviewed Journal of Clinical Microbiology.

Dr. Patton’s areas of expertise are Anatomic Pathology, Clinical Pathology, and Cytopathology with sub-specialty expertise in Laboratory Administration. He is the chief pathologist and Medical Director of Clinical Laboratories at UW Medicine/Northwest Hospital & Medical Center, acts as the Washington State Commissioner for the College of American Pathologists Laboratory Accreditation Program, is an Associate Clinical Professor of Pathology at University of Washington and is a published international thought leader on blood culture contamination.